ATTGENO AB
Developing targeted nitric oxide delivery drugs for critical care applications.
Overview
- 2
- Employees
- 0 SEK
- Revenue
- 2005
- Founded
Description
Attgeno is a Swedish biotechnology company focused on saving patient lives through advanced drug delivery systems. Their core mission revolves around the targeted delivery of nitric oxide (NO), a vital molecule in various physiological processes. The company is pioneering the third generation of NO...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556692775101
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in Funnelfeedr
Cereno Scientific AB
10–19 employeesPioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
LobSor Pharmaceuticals Aktiebolag
3 employeesDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
MucoLife Therapeutics AB
1–4 employeesDeveloping novel mucus modulators to treat COPD and Cystic Fibrosis.
Sangair AB
3 employeesDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Omnio Healer AB
0 employeesDeveloping regenerative plasminogen therapy to heal chronic wounds effectively.
Browse More
ATTGENO AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo